Oncology and Emerging Applications

The broader CgA–CST platform is also being explored in oncology and other disease areas in which metabolic dysregulation, inflammation, cellular stress, and altered signaling contribute to disease progression.

These emerging areas may broaden the potential therapeutic applications of CST-related technologies and form part of CgA Therapeuticals' expanding intellectual-property and discovery portfolio.